Objective: We studied the ante-and postnatal risk factors and clinical outcomes associated with pulmonary interstitial emphysema (PIE) in extremely low birth weight infants (ELBW, <1000 g at birth) in the present era of tocolytics, antenatal steroid and postnatal surfactant administration.
Introduction
Pulmonary interstitial emphysema (PIE) is an acute pulmonary complication seen in mechanically ventilated newborn infants with respiratory distress syndrome (RDS). [1] [2] [3] The risk factors for PIE have not been systematically evaluated, especially since the recent advancements in antenatal care of mothers in preterm labor (PTL). Although suggested to be related directly to the degree of positive pressure ventilation received, PIE has been reported in infants who were never ventilated. 4 PIE is considered to be a significant contributory factor in the pathogenesis of bronchopulmonary dysplasia (BPD). 2 In this study, we examined the ante-and postnatal risk factors and clinical outcomes associated with PIE in extremely low birth weight infants, who weighed <1000 g at birth (ELBW).
Materials and methods
The study population comprised of all ELBW infants who were admitted consecutively to the Neonatal Intensive Care Unit (NICU) of the university hospital of State University of New York at Stony Brook between January 2000 and June 2001. Those infants who suffered from chromosomal anomalies, major congenital malformation of any organ system or hydrops fetalis were excluded. The study was approved by the institutional review board for research involving human subjects.
The hospital charts of all infants were retrospectively reviewed for the following variables: birth weight (BW), gestational age (GA), sex, Apgar scores at 1 and 5 min of life, the doses of exogenous surfactant at birth for RDS, the maximum daily mean airway pressure (MAP) and maximum daily fractional inspired oxygen concentration (FiO 2 ) during the first 7 days of life, daily cumulative fluid volume intake and output during the first 7 days of life, the occurrence of PIE, patent ductus arteriosus (PDA), grade 2 or higher intraventricular-periventricular hemorrhage (IVH), BPD (defined as oxygen requirement on day of life 28), periventricular leukomalacia (PVL), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) X stage 2, death within 28 days of life, and ultimate length of stay (LOS). The surfactant preparation used in the entire study population was beractant (Ross Products Division, Abbot Laboratories, Columbus, OH, USA).
The maternal charts of all infants studied were examined for the presence of pregnancy induced hypertension (PIH), gestational or pre-existing diabetes mellitus (DM), chorioamnionitis, the duration of rupture of membrane if more than 24 h (PROM), preterm labor (PTL) lasting for X12 h, smoking and other substance abuse during pregnancy and treatment with antenatal steroid (ANS) or antibiotics. Clinical chorioamnionitis was diagnosed when a maternal axillary temperature elevation to 37.81C was accompanied with two or more of the following criteria: uterine tenderness, malodorous vaginal discharge, maternal leucocytosis (>15 000 mm 3 ), maternal tachycardia (>100 beats/ min) and fetal tachycardia (>160 beats/min).
The types of tocolytic agent used and cumulative doses of magnesium sulfate (MgSO 4 ) were also recorded in each maternalinfant pair. Neonates exposed to MgSO 4 for tocolysis as well as for seizure prophylaxis for maternal pre-eclampsia were included. The cumulative dose and duration of MgSO 4 therapy was prescribed at the discretion of the attending obstetricians. RDS, PIE and NEC (Stage II or higher according to the modified Bell's staging criteria) were diagnosed clinically and radiologically by an independent radiologist who was unaware of the antenatal history of the infant. Each neonate had a transfontanelle neurosonography performed between days of life 1 and 3, and subsequently at the discretion of the neonatologist. Neurosonograms were also evaluated by an experienced neuroradiologist who was unaware of the clinical course and complications of the study cohort. IVH was graded according to the Papile's classification. 5 Periventricular leucomalacia was diagnosed as echolucent area or areas of persistent echogenicity in the periventricular region of the brain in coronal and sagittal views. ROP was diagnosed and classified by an expert ophthalmologist who was blinded to the course and complication or magnesium exposure of the infants. PDA was diagnosed by the use of echocardiography in the presence of relevant clinical signs. Neonatal death was defined as death within 28 days of postnatal life.
The infants were divided into two groups, those who developed PIE on chest radiograph and those who did not. All cases of PIE, including those which were described as minimal or unilateral, were included in the study. All maternal and infant variables were compared between the PIE and non-PIE groups. The Student's ttest was utilized to compare the continuous and Fisher's exact and w 2 tests were used for the categorical data in univariate analysis. The ordinal and non-normally distributed continuous variables were compared by utilizing Wilcoxon rank sums tests. Multivariate logistic regression analysis was performed to control for the effects of potential confounders. P-value was set at 0.05 for significance. Data were processed using statistical software SPSS 10.7 (SPSS Inc., Chicago, IL, USA).
Results
A total of 45 infants were eligible and included in the analysis. All infants included in the study were treated with conventional ventilator in the assist-control mode before the onset of PIE. Out of these infants 11 developed PIE (24%). The median day of life when PIE was first radiologically diagnosed was 2.5 days with a range of 1-9 days and the median duration of PIE was13 days with a range of 2-32 days. The mean and s.d. of maximum positive inspiratory pressure (PIP) on the first day of radiological appearance of PIE was 16.6±5.8 cm/H 2 O.
The comparative maternal and neonatal variables are presented in Tables 1-3 . The GA, BW, and sex, did not differ between the groups whereas Apgar scores at 1 and 5 min were lower in the PIE group (P ¼ 0.04 and 0.003, respectively). The average maximum MAP and FiO 2 during the first 7 days of life were higher in PIE group (P ¼ 0.02 and 0.04, respectively). Infants with PIE received more doses of surfactant (P ¼ 0.0004) and higher total dose of MgSO 4 than non-PIE group (0.02). The neonatal mortality was 37% in the PIE group compared to 6% in non-PIE group (P ¼ 0.01).
We identified that only one of the infants whose mothers received MgSO 4 in cumulative doses <10 g developed PIE. On further analysis, 54% of infants with PIE were exposed to X10 g of MgSO 4 (Mg10) compared to only 15% in the non-PIE group (P ¼ 0.01). Mg10 remained significantly associated with PIE after controlling for the significant predictors identified by univariate testing in a multivariate logistic regression analysis model which included maximum mean FiO 2 and MAP during first 7 days of life, 1 and 5 min Apgar scores, GA and surfactant requirement (OR 19.8, 95% CI 1.5-263, P ¼ 0.01). The duration of PTL was longer than 12 h in 75% of infants who received Mg10 compared to 40% who did not receive Mg10 (P ¼ 0.08).
Only one mother in the PIE group received MgSO 4 for PIH (9%) compared to four in non-PIE group (11%, P ¼ 0.7). Nine infants out of 45 received additional tocolysis with indomethacin and terbutaline, out of which four were in the PIE group (36%) and five in non-PIE group (15%, P ¼ 0.09).
Discussion
The pathogenesis of PIE is not well investigated and subject to various proposed hypotheses. Pulmonary interstitial emphysema is generally associated directly with the degree of mechanical ventilation. Our results suggest that ELBW infants who develop PIE suffer from more severe respiratory distress as indicated by increased surfactant and ventilatory support administration during the first week of their lives. These infants are also more likely to die during the neonatal period despite comparable immaturity with controls. We found that in utero exposure to MgSO 4 especially in cumulative doses higher than 10 g is an independent risk factor for PIE in ELBW infants. This risk factor for PIE was not previously reported. In addition, the infants with PIE had lower Apgar scores, which suggested depression and hypotonia in the immediate postnatal period, both of which could be related to the toxicity of MgSO 4 . Even though the study is limited by a retrospective design and small number of patients in the PIE group, these results are clinically relevant. It is not clear if mortality in our cohort was due to PIE and subsequent respiratory failure or antenatal MgSO 4 exposure, or a combination of both. Magnesium sulfate tocolysis has been associated with various neonatal morbidities and mortality. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The specific association of PIE with increased mortality in ELBW infants was not previously documented. Preterm labor is associated with elevated concentrations of fetal proinflammatory cytokines and other mediators. 22 It is possible that the fetal exposure to higher doses of MgSO 4 in an environment of high concentrations of proinflammatory cytokines produces specific adverse changes in the developing pulmonary tissue which favors PIE when infants are postnatally subjected to alveolar stretching during positive pressure ventilation. When labor is further diminished with tocolytics the prolonged exposure may have serious consequences for the developing lung and other organs, which may eventually precipitate death. Mittendorf and associates demonstrated an increased incidence of death with exposure to tocolytic MgSO 4 but did not identify a possible mechanism.
9-11 Scudiero et al. concluded that antenatal exposure to MgSO 4 in doses >48 g is associated with increased perinatal mortality with a significant dose-response which is consistent with a threshold effect as demonstrated by the Cochrane-Armitage trend test. 8 The risk of death was found to be higher in preterm infants who were exposed to MgSO 4 in a Cochrane database review which included seven trials and 727 infants. 23 The results of another review from Europe were consistent with this conclusion. 24 The biological mechanism of PIE or neonatal mortality due to antenatal MgSO 4 exposure is not clear. Magnesium sulfate is known to inhibit cytoplasmic calcium influx, cause systemic and cerebral vasodilatation and induce immunomodulation. [25] [26] The last one may be an important factor in modulating inflammatory response that may result from overt or occult chorioamnionitis or an acute intrapartum event, both of which have been associated with PTL.
There was a trend towards the occurrence of more severe IVH in infants with PIE in our cohort, which did not reach significance probably due to a b error. This association has not been previously reported. The etiopathogenesis of IVH is mulifactorial and the acuity of respiratory disease with administration of higher ventilatory support in the PIE group might be a possible causative factor. 27 The data regarding antenatal MgSO 4 and IVH is not entirely conclusive even though Mittendorf found a higher incidence of IVH with magnesium tocolysis in infants <34 weeks of gestation. 11 In a large study involving 1409 infants the relative risk of IVH with maternal receipt of MgSO 4 was 1 (CI 0.7-1.3). The multivariate analysis using a model that controlled the significant covariates yielded a strong Odds ratio for the dosespecific relationship between MgSO 4 and PIE in our study. A higher incidence of neonatal mortality in this cohort of ELBW infants who were exposed to high doses of MgSO 4 and suffered from PIE raises questions about the safety of prolonged tocolysis with this pharmacological agent in fetuses who are viable but <1000 g in estimated fetal weight. This issue merits further investigation.
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